Belgium stands out as a hub of healthcare innovation, powered by a dynamic ecosystem that brings together companies, healthcare professionals, governmental stakeholders, and associations. This network fosters collaboration and investment in biotech, medtech, and biomanufacturing excellence, continually reinforcing Belgium’s position as a global leader in life sciences. Its innovative spirit also extends across the entire healthcare value chain, from research into new therapies to attractive clinical trial regulations and advanced manufacturing capabilities.
Beyond innovation, Belgium is also widely recognised for the comprehensive coverage and accessibility of its healthcare system. But this system is undergoing a rapid transformation driven not only by groundbreaking innovations, but also evolving patient needs, and a growing emphasis on value and accessibility. These shifts demand continuous attention and investment into innovative solutions to overcome the challenges they may bring.
Key challenges shaping the sector include rising demand for medical services, workforce shortages, financial pressures, sustainability concerns and the need for effective change management.
Our extensive network of experts provides deep insights and practical solutions across the healthcare value chain. We work with policymakers, payers, pharmaceutical companies, and device manufacturers to develop and implement effective strategies. From supporting start-ups seeking funding to helping global manufacturers optimise operations, we bring a wealth of expertise to every stage of the healthcare journey.
Our holistic approach helps us offer fresh perspectives on technology, change management, operational models and patient care – helping you navigate challenges and drive the future of healthcare.
Value drivers
- Value based healthcare in Belgium: Delivering better outcomes while optimising costs
- Medtech, biotech and pharma: Driving innovation
- Advanced Therapies - Biomanufacturing: The Future is Now
- Decentralised clinical trials: Revolutionizing research and patient care
- Patient engagement: Empowering individuals for better health outcomes
Value based healthcare in Belgium: Delivering better outcomes while optimising costs
The Belgian healthcare system faces significant challenges. Taking them on requires a fundamental shift towards a model that encourages quality of care and improved health outcomes. Value-Based-Healthcare (VBHC) – which focuses on delivering better outcomes for individuals while optimizing costs – is gaining traction as a more effective and efficient approach. But its adoption requires rethinking how healthcare is delivered, measured, and reimbursed.
Explore our insights on defining and measuring value, aligning financial and clinical incentives, and building the infrastructure needed to succeed in a VBHC environment.
Explore our insights
A New Era in Belgian Healthcare The future of care Next in health services 2025
Medtech, biotech and pharma: Driving innovation
Belgium is a hub of life sciences innovation, with a robust ecosystem supporting advancements in medtech, biotech, and pharmaceuticals. The country’s strategic location, skilled workforce, and supportive regulatory framework attract significant investments and foster groundbreaking research. Ongoing initiatives, such as the multi-year pharmaceutical framework and the National Clinical Trial Network, underscore the country’s commitment to life science excellence.
Advanced Therapies - Biomanufacturing: The Future is Now
Belgium is emerging as a hub for advanced therapies, particularly in cell and gene therapy, offering hope for previously incurable diseases. As an EU leader in Advanced Therapy Medicinal Products (ATMP) research and development, Belgium supports the ATMP ecosystem through public and private initiatives, with key players like flanders.bio, BioWin, and Pharma.be driving progress.
However, realizing ATMP’s full potential faces challenges in biomanufacturing, logistics, regulatory pathways, and reimbursement. Belgium’s rigid reimbursement system struggles to accommodate ATMP-specific needs, often leading to complex payer negotiations that hinder patient access. Efforts are underway to develop innovative payment models to address these barriers. A major hurdle is the lack of government funding for ATMP scale-up. While Belgium has a strong biotech ecosystem, companies struggle to transition from development to large-scale production due to limited financial and infrastructure support, pushing them to expand elsewhere.
PwC Belgium is driving this transformation, collaborating with research institutions and pharmaceutical companies to accelerate ATMP adoption. Explore our insights on how to navigate the complexities of biomanufacturing, optimize your supply chain, and ensure patient access to these life-changing treatments.
Decentralised clinical trials: Revolutionizing research and patient care
Decentralised Clinical Trials (DCTs) are transforming medical research as we know it, in Belgium and beyond. By leveraging digital technologies and innovative approaches, they are breaking down traditional barriers and expanding access to novel treatments. This patient centric model enhances participant diversity, improved retention rates, and enables more efficient data collection.
In 2025, DCT adoption has become significant, with studies demonstrating that trials using decentralised elements are more likely to meet enrolment timelines and achieve market approval.
PwC Belgium is at the forefront of this revolution. Our role? Helping pharmaceutical companies, CROs, and healthcare providers navigate the complexities of DCT implementation. We also offer expertise in regulatory compliance, technology integration, and operational optimisation, to ensure that DCTs not only improve patient experience but also accelerate the development of life-changing therapies. We work closely with stakeholders with one purpose: Designing and implementing DCT strategies that align with Belgium’s commitment to innovation in clinical research and its position as a leader in European healthcare.
Explore our insights
Patient engagement: Empowering individuals for better health outcomes
Patients today expect greater transparency, personalisation and control over their healthcare decisions. Meaningful patient engagement is key to improving outcomes, enhancing satisfaction, and reducing overall healthcare costs.
At PwC Belgium, we help organisations design and implement patient-centric strategies, leveraging digital technologies and data analytics to empower individuals in their healthcare journeys.
Our insights support organisations in fostering stronger patient relationships, improving communication, and delivering truly personalised care experiences.
Explore our insights
How to boost go-to-market strategies in the pharma industry Advancing market access
Future Trends: PwC Thought Leadership
If you want to know more about PwC and how we view the future of healthcare, read our thought leadership contributions.
Contact us
